CN100352497C - 应用特异性结合cd40cr(cd40 配体)的抗体抑制体液免疫 - Google Patents
应用特异性结合cd40cr(cd40 配体)的抗体抑制体液免疫 Download PDFInfo
- Publication number
- CN100352497C CN100352497C CNB200410078988XA CN200410078988A CN100352497C CN 100352497 C CN100352497 C CN 100352497C CN B200410078988X A CNB200410078988X A CN B200410078988XA CN 200410078988 A CN200410078988 A CN 200410078988A CN 100352497 C CN100352497 C CN 100352497C
- Authority
- CN
- China
- Prior art keywords
- cell
- antibody
- cd40cr
- mice
- activation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2875—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5448898A | 1998-04-03 | 1998-04-03 | |
| US09/054488 | 1998-04-03 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB998067563A Division CN1173735C (zh) | 1998-04-03 | 1999-04-02 | 抗-gp39抗体在狼疮及相关肾病的治疗和/或逆转中的应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1757413A CN1757413A (zh) | 2006-04-12 |
| CN100352497C true CN100352497C (zh) | 2007-12-05 |
Family
ID=21991433
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB200410078988XA Expired - Fee Related CN100352497C (zh) | 1998-04-03 | 1999-04-02 | 应用特异性结合cd40cr(cd40 配体)的抗体抑制体液免疫 |
| CNB998067563A Expired - Fee Related CN1173735C (zh) | 1998-04-03 | 1999-04-02 | 抗-gp39抗体在狼疮及相关肾病的治疗和/或逆转中的应用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB998067563A Expired - Fee Related CN1173735C (zh) | 1998-04-03 | 1999-04-02 | 抗-gp39抗体在狼疮及相关肾病的治疗和/或逆转中的应用 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1067954A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2002510643A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20010072564A (cg-RX-API-DMAC7.html) |
| CN (2) | CN100352497C (cg-RX-API-DMAC7.html) |
| AU (1) | AU743824B2 (cg-RX-API-DMAC7.html) |
| HU (1) | HUP0101689A3 (cg-RX-API-DMAC7.html) |
| NO (1) | NO20004966L (cg-RX-API-DMAC7.html) |
| TW (1) | TWI224969B (cg-RX-API-DMAC7.html) |
| WO (1) | WO1999051258A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA41459A (fr) | 2015-02-03 | 2017-12-12 | Als Therapy Development Inst | Anticorps anti-cd40l et méthodes pour traiter des maladies ou des troubles liés aux cd40l |
| MY188405A (en) | 2015-08-05 | 2021-12-08 | Janssen Biotech Inc | Anti-cd154 antibodies and methods of using them |
| EP3630843A2 (en) | 2017-05-24 | 2020-04-08 | ALS Therapy Development Institute | Therapeutic anti-cd40 ligand antibodies |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5474771A (en) * | 1991-11-15 | 1995-12-12 | The Trustees Of Columbia University In The City Of New York | Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes, compositions containing same |
| WO1996023071A2 (en) * | 1995-01-26 | 1996-08-01 | Bristol-Myers Squibb Company | MONOCLONAL ANTIBODIES SPECIFIC FOR DIFFERENT EPITOPES OF HUMAN gp39 AND METHODS FOR THEIR USE IN DIAGNOSIS AND THERAPY |
| US5672347A (en) * | 1984-07-05 | 1997-09-30 | Genentech, Inc. | Tumor necrosis factor antagonists and their use |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2089229C (en) * | 1992-02-14 | 2010-04-13 | Alejandro A. Aruffo | Cd40cr receptor and ligands therefor |
| US5833987A (en) * | 1995-06-07 | 1998-11-10 | Trustees Of Dartmouth College | Treatment of T cell mediated autoimmune disorders |
| US6001358A (en) * | 1995-11-07 | 1999-12-14 | Idec Pharmaceuticals Corporation | Humanized antibodies to human gp39, compositions containing thereof |
| CN1572325A (zh) * | 1997-01-10 | 2005-02-02 | 拜奥根Idec马萨诸塞公司 | 用抗cd40l化合物治疗狼疮性肾炎 |
| WO1998039026A2 (en) * | 1997-03-07 | 1998-09-11 | Biogen, Inc. | Methods of therapeutic administration of anti-cd40l compounds |
| WO1999000143A1 (en) * | 1997-06-27 | 1999-01-07 | Biogen, Inc. | Cd154 blockade therapy for autoimmune diseases |
-
1999
- 1999-04-02 CN CNB200410078988XA patent/CN100352497C/zh not_active Expired - Fee Related
- 1999-04-02 JP JP2000542029A patent/JP2002510643A/ja not_active Withdrawn
- 1999-04-02 WO PCT/US1999/007321 patent/WO1999051258A1/en not_active Ceased
- 1999-04-02 AU AU33796/99A patent/AU743824B2/en not_active Withdrawn - After Issue
- 1999-04-02 KR KR1020007011045A patent/KR20010072564A/ko not_active Ceased
- 1999-04-02 CN CNB998067563A patent/CN1173735C/zh not_active Expired - Fee Related
- 1999-04-02 HU HU0101689A patent/HUP0101689A3/hu unknown
- 1999-04-02 EP EP99915237A patent/EP1067954A4/en not_active Withdrawn
- 1999-06-28 TW TW088105322A patent/TWI224969B/zh not_active IP Right Cessation
-
2000
- 2000-10-02 NO NO20004966A patent/NO20004966L/no not_active Application Discontinuation
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5672347A (en) * | 1984-07-05 | 1997-09-30 | Genentech, Inc. | Tumor necrosis factor antagonists and their use |
| US5474771A (en) * | 1991-11-15 | 1995-12-12 | The Trustees Of Columbia University In The City Of New York | Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes, compositions containing same |
| WO1996023071A2 (en) * | 1995-01-26 | 1996-08-01 | Bristol-Myers Squibb Company | MONOCLONAL ANTIBODIES SPECIFIC FOR DIFFERENT EPITOPES OF HUMAN gp39 AND METHODS FOR THEIR USE IN DIAGNOSIS AND THERAPY |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20010072564A (ko) | 2001-07-31 |
| TWI224969B (en) | 2004-12-11 |
| AU3379699A (en) | 1999-10-25 |
| CN1173735C (zh) | 2004-11-03 |
| JP2002510643A (ja) | 2002-04-09 |
| HUP0101689A3 (en) | 2004-08-30 |
| CN1303301A (zh) | 2001-07-11 |
| EP1067954A4 (en) | 2004-08-18 |
| EP1067954A1 (en) | 2001-01-17 |
| AU743824B2 (en) | 2002-02-07 |
| NO20004966D0 (no) | 2000-10-02 |
| HUP0101689A2 (hu) | 2001-08-28 |
| CN1757413A (zh) | 2006-04-12 |
| NO20004966L (no) | 2000-12-04 |
| WO1999051258A1 (en) | 1999-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4148537B2 (ja) | Cd40crレセプター及びそれに対するリガンド | |
| Daridon et al. | Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome | |
| CN104619722B (zh) | 新型vista-ig构建体和vista-ig用于治疗自身免疫性、过敏性和炎性疾病的用途 | |
| AU2013312211B2 (en) | VISTA modulators for diagnosis and treatment of cancer | |
| Contin et al. | Potential role of soluble CD40 in the humoral immune response impairment of uraemic patients | |
| TWI222453B (en) | Ligand for herpes simplex virus entry mediator and methods of use | |
| EA015351B1 (ru) | Антагонисты il-17a и il-17f и способы их применения | |
| Zone et al. | IgA autoimmune disorders: development of a passive transfer mouse model | |
| Segal et al. | The subclass specificity for the binding of murine myeloma proteins to macrophage and lymphocyte cell lines and to normal spleen cells | |
| ES2747920T3 (es) | Anticuerpo anti-NKP46 para diagnóstico de un linfoma de células T periféricas no cutáneo (PTCL) | |
| JPS62116599A (ja) | 医薬組成物 | |
| JPH09502708A (ja) | Il4により伝達される疾患の治療に有用な組み換え型il4抗体 | |
| EP0872488B1 (en) | MONOCLONAL ANTIBODY REACTING SPECIFICALLY WITH Fas LIGAND AND PROCESS FOR PRODUCING THE SAME | |
| US20080254033A1 (en) | Pharmaceutical Compositions Containing Antagonists to Lrp4, Lrp8 or Megalin for Treatment of Diseases | |
| CN106573976A (zh) | 抗cd84抗体、包含所述抗体的组合物及其用途 | |
| US20230014398A1 (en) | Anti-b7-h3 monoclonal antibody and methods of use thereof | |
| Hoshino et al. | Cell kinetic analysis of human brain tumors by in situ double labelling with bromodeoxyuridine and iododeoxyuridine | |
| US20220389106A1 (en) | Anti-epha10 antibodies and methods of use thereof | |
| US6472510B1 (en) | CD40 receptor ligands | |
| Takayama et al. | Antigen-specific directional target cell lysis by perforin-negative T lymphocyte clones | |
| AU743824B2 (en) | Use of anti-gp39 antibodies for treatment and/or reversal of lupus and associated kidney disease | |
| Ronda et al. | Anti-fibroblast antibodies in systemic sclerosis | |
| US20020058037A1 (en) | Use of anti-gp-39 antibodies for treatment and/or reversal of lupus and lupus associated kidney disease | |
| HK1067887A (en) | Antibodies that bind the cd40cr receptor | |
| HOSHIN04 et al. | Publlcatlon zyxwvutsrqponml |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20071205 |